Top

Published in:

01-08-2020 | Deep Brain Stimulation | Letter to the Editor

A case of refractory hypernatremia in the setting of parkinsonism–hyperpyrexia syndrome

Authors: Ho-Sung Ryu, Seok-Yeol Yang

Published in: Acta Neurologica Belgica | Issue 4/2020

Excerpt

Parkinsonism–hyperpyrexia syndrome (PHS) is a rare, but life-threatening condition in patients with Parkinson’s disease (PD). The clinical features of PHS include muscle rigidity, hyperthermia, altered mental status, and autonomic instability. Laboratory findings in these patients may indicate an increased creatine kinase, leukocytosis, deranged liver function tests, and metabolic acidosis [1]. Primarily, rapid recognition of PHS is critical to appropriately treat these patients. Herein, we report a patient with PD dementia who developed hypernatremia in the setting of PHS. This was successfully resolved by administering levodopa therapy. …

Newman EJ, Grosset DG, Kennedy PGE (2009) The parkinsonism-hyperpyrexia syndrome. Neurocrit Care 10(1):136–140. https://doi.org/10.1007/s12028-008-9125-4 CrossRefPubMed

Volkmann J (2013) Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson's disease commentary. Movem Disord 28(12):1642–1642. https://doi.org/10.1002/mds.256663 CrossRef

Serrano-Duenas M (2003) Neuroleptic malignant syndrome-like, or—dopaminergic malignant syndrome—due to levodopa therapy withdrawal. Clinical features in 11 patients. Parkinsonism Relat Disord 9(3):175–178. https://doi.org/10.1016/s1353-8020(02)00035-4 CrossRefPubMed

Azar J, Elinav H, Safadi R, Soliman M (2019) Malignant deep brain stimulator withdrawal syndrome. BMJ Case Rep 12(5):e229122. https://doi.org/10.1136/bcr-2018-229122 CrossRefPubMedPubMedCentral

Cao L, Katz RH (1999) Acute hypernatremia and neuroleptic malignant syndrome in Parkinson disease. Am J Med Sci 318(1):67–68. https://doi.org/10.1097/00000441-199907000-00011 CrossRefPubMed

Title: A case of refractory hypernatremia in the setting of parkinsonism–hyperpyrexia syndrome
Authors: Ho-Sung Ryu
Seok-Yeol Yang
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Deep Brain Stimulation
Parkinson's Disease
Hypernatremia
Levodopa
Published in: Acta Neurologica Belgica / Issue 4/2020
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-020-01316-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A case of refractory hypernatremia in the setting of parkinsonism–hyperpyrexia syndrome

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

A complication of coronavirus disease 2019: delirium

Myelitis with normal spinal cord MRI: don't forget anti-MOG antibodies disease!

Selective intra-arterial recombinant tissue-plasminogen activator in a case of acute posterior inferior cerebellar artery occlusion

Double whammy: a concurrence of two disorders with a shared trigger

Predictive value of laboratory parameters in childhood migraine

Erythropoietin-induced cluster of seizures in two children with cerebral palsy